Who invested in Rondo Therapeutics?
Rondo Therapeutics's investors include Canaan, Novo Holdings and SV Health Investors.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$67Mraised across 1 round since 2022, from 1 source
From Rondo Therapeutics's own website: 1 on the team.
AdvisersSteven James
Rondo Therapeutics's investors include Canaan, Novo Holdings and SV Health Investors.
Rondo Therapeutics has raised $67M across 1 round since 2022.
Rondo Therapeutics's most recent round was a Series A of $67M in Mar 2022.
Its most recent round, $67M in Mar 2022, is also its largest on record.
Rondo Therapeutics's first round on record, in Mar 2022, was backed by Canaan, Novo Holdings and SV Health Investors.
Rondo Therapeutics's latest named round is a Series A, in Mar 2022.
Rondo Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.